UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic study

The Journal of thoracic and cardiovascular surgery, 1999-04, Vol.117 (4), p.759-765

1999

Volltextzugriff (PDF)

Comparative Effects of Paclitaxel and Docetaxel on the Metabolism and Pharmacokinetics of Epirubicin in Breast Cancer Patients

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1132-1140

1999

Volltextzugriff (PDF)

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients

Annals of oncology, 2003-08, Vol.14 (8), p.1222-1226

2003

Volltextzugriff (PDF)

Docetaxel Pharmacokinetics with Pre- and Post-Dialysis Administration in a Hemodyalized Patient

Chemotherapy (Basel), 2006-01, Vol.52 (3), p.147-150

2006

Volltextzugriff (PDF)

Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancer

Annals of oncology, 2002-02, Vol.13 (2), p.280-285

2002

Volltextzugriff (PDF)

Sequence Effect of Epirubicin and Paclitaxel Treatment on Pharmacokinetics and Toxicity

Journal of clinical oncology, 2000-05, Vol.18 (10), p.2116-2125

2000

Volltextzugriff (PDF)

Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic study

European journal of surgical oncology, 2002-03, Vol.28 (2), p.172-179

2002

Volltextzugriff (PDF)

Cisplatin combined with the new cisplatin-procaine complex dpr: In vitro and in vivo studies

European journal of cancer (1990), 1996-12, Vol.32 (13), p.2327-2333

1996

Volltextzugriff (PDF)

Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion

Annals of oncology, 1997-04, Vol.8 (4), p.385-391

1997

Volltextzugriff (PDF)

Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II)

Toxicology and applied pharmacology, 1996-10, Vol.140 (2), p.370-377

1996

Volltextzugriff (PDF)

High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule

British journal of cancer, 1997, Vol.76 (6), p.797-804

1997

Volltextzugriff (PDF)

Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells

Anticancer research, 1999-01, Vol.19 (1B), p.879

1999

Volltextzugriff (PDF)

Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis

Anticancer research, 1998-03, Vol.18 (2B), p.1313

1998

Volltextzugriff (PDF)

Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride

Anticancer research, 1992-11, Vol.12 (6B), p.2285

1992

Volltextzugriff (PDF)

Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer

Anticancer research, 1998-01, Vol.18 (1B), p.517

1998

Volltextzugriff (PDF)

Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?

The Journal of pharmacology and experimental therapeutics, 2000-06, Vol.293 (3), p.829

2000

Volltextzugriff (PDF)

Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia

Anticancer research, 1993-09, Vol.13 (5A), p.1511

1993

Volltextzugriff (PDF)

Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity

Carcinogenesis (New York), 1993-12, Vol.14 (12), p.2595-2599

1993

Volltextzugriff (PDF)

Suramin/epidoxorubicin association in hormone-refractory prostate cancer : preliminary results of a pilot phase II study

Journal of cancer research and clinical oncology, 1997, Vol.123 (7), p.407-410

1997

Volltextzugriff (PDF)

Time-dependent influence of procaine hydrochloride on cisplatin antitumor activity in P388 tumor bearing mice

Anticancer research, 2001-01, Vol.21 (1A), p.485

2001

Volltextzugriff (PDF)

Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines

Anti-cancer drugs, 1998-06, Vol.9 (5), p.457-463

1998

Volltextzugriff (PDF)

In situ lung perfusion with cisplatin an experimental study

Cancer, 1993-05, Vol.71 (10), p.2962-2970

1993

Volltextzugriff (PDF)

Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats

European journal of pharmacology, 2002-05, Vol.442 (3), p.265-272

2002

Volltextzugriff (PDF)

First line treatment of HER-2/neu positive advanced breast cancer patients with liposomal doxorubicin (Myocet), docetaxel and trastuzumab. A phase I-II study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10744-10744

2006

Volltextzugriff (PDF)

Effect of hyaluronidase on the pharmacokinetics of free and total platinum species after intra-arterial Cisplatin in refractory patients with colorectal liver metastases

Clinical drug investigation, 1996-08, Vol.12 (2), p.94-104

1996

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(44)

Sprache

Englisch
(41)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Pharmacology. Drug Treatments
(22)
Female
(21)
Humans
(21)
Oncology
(20)
Antineoplastic Agents
(17)
Male
(16)
Chemotherapy
(15)
Animals
(13)
Middle Aged
(11)
Aged
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Cisplatin - Administration & Dosage
(9)
Pharmacology & Pharmacy
(9)
Mice
(8)
Breast Neoplasms - Drug Therapy
(7)
Cisplatin
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic study

Comparative Effects of Paclitaxel and Docetaxel on the Metabolism and Pharmacokinetics of Epirubicin in Breast Cancer Patients

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients

Docetaxel Pharmacokinetics with Pre- and Post-Dialysis Administration in a Hemodyalized Patient

Influence of alternate sequences of epirubicin and docetaxel on the pharmacokinetic behaviour of both drugs in advanced breast cancer

Sequence Effect of Epirubicin and Paclitaxel Treatment on Pharmacokinetics and Toxicity

Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic study

Cisplatin combined with the new cisplatin-procaine complex dpr: In vitro and in vivo studies

Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion

Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II)

High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule

Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells

Hydration regimen and hematological toxicity of a cisplatin-based chemotherapy regimen. Clinical observations and pharmacokinetic analysis

Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride

Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer

Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?

Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia

Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity

Suramin/epidoxorubicin association in hormone-refractory prostate cancer : preliminary results of a pilot phase II study

Time-dependent influence of procaine hydrochloride on cisplatin antitumor activity in P388 tumor bearing mice

Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines

In situ lung perfusion with cisplatin an experimental study

Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats

First line treatment of HER-2/neu positive advanced breast cancer patients with liposomal doxorubicin (Myocet), docetaxel and trastuzumab. A phase I-II study

Effect of hyaluronidase on the pharmacokinetics of free and total platinum species after intra-arterial Cisplatin in refractory patients with colorectal liver metastases

Suchergebnisse filtern